Metformin for preventing cancer in oral leukoplakia
Treatments studied
Part of Cancer, Mouth & dental clinical trials.
This study tests if metformin — a medication commonly used for diabetes — can prevent oral leukoplakia from turning into cancer when applied as a mouth rinse and taken as a pill. It is for people with non-severe white patches in the mouth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 21 years or older.
- You have a biopsy-confirmed mouth white patch (oral leukoplakia) with mild to moderate cell changes.
- You are not currently taking metformin or certain stomach acid medications (like ranitidine).
- You do not have serious heart, lung, kidney, or liver disease.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a cream containing coenzyme Q10 and curcumin can help treat a common mouth condition called oral leukoplakia (a white patch that can sometimes turn into cancer). It is for people with a specific type of white patch that is not severe and can be easily reached with a cream.
This trial studies whether a two-medicine diabetes drug combination can reduce or control risky early changes in certain mouth and throat lesions. You may be asked for small tissue samples (biopsies) before and after 12 weeks to see how the lesions respond.
This study looks at oral leukoplakia (persistent white patches in the mouth) to better predict which ones may develop into cancer. It uses a test based on specific immune and cancer-related markers to help estimate each person’s risk.
This study tests whether a light-based treatment (photodynamic therapy) works better than a vitamin D cream (calcipotriol) for treating white patches in the mouth that could become cancer. Both treatments are applied directly to the patch.
This trial tests a low-cost approach to find and treat early mouth cancers or precancerous spots using a special light-activated drug (photodynamic therapy). The goal is to destroy the abnormal cells while sparing healthy tissue.
This Phase 2 study tests whether metformin can lower the risk of leukemia developing in people with low-risk myelodysplastic syndrome (LR-MDS) or CCUS. You may be considered if your blood counts have stayed low and other causes have been ruled out.
Hear when a new Oral Leukoplakia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.